What Do We Really Know about How CD4 T Cells Control ?

1. GallegosAMvan HeijstJWJSamsteinMSuXPamerEG 2011 A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo. PLoS Pathog 7 e1002052 doi:10.1371/journal.ppat.1002052

2. BoldTDBanaeiNWolfAJErnstJD 2011 Suboptimal activation of antigen-specific CD4+ effector cells enables persistence of M. tuberculosis in vivo. PLoS Pathog 7 e1002063 doi:10.1371/journal.ppat.1002063

3. CooperAM 2009 Cell mediated immune responses in tuberculosis. Annu Rev Immunol 27 393 422

4. StruttTMMcKinstryKKDibbleJPWinchellCKuangY 2010 Memory CD4+ T cells induce innate responses independently of pathogen. Nat Med 16 558 564

5. ShafianiSTucker-HeardGKariyoneATakatsuKUrdahlKB 2010 Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med 207 1409 1420

6. WinslowGMRobertsADBlackmanMAWoodlandDL 2003 Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J Immunol 170 2046 2052

7. TamuraTArigaHKinashiTUeharaSKikuchiT 2004 The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model. Int Immunol 16 1691 1699

8. EgenJGRothfuchsAGFengCGHorwitzMASherA 2011 Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity 34 807 819

9. CooperAMayer-BarberKSherA 2011 Role of innate cytokines in mycobacterial infection. Mucosal Immunol 4 252 260

10. ShiLJungYTyagiSGennaroMNorthR 2003 Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proc Natl Acad Sci U S A 100 241 246

11. AagaardCHoangTDietrichJCardonaP-JIzzoA 2011 A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 17 189 194

12. TorradoERobinsonRTCooperAM 2011 Cellular response to mycobacteria: balancing protection and pathology. Trends Immunol 32 66 72